Sophoraflavone ACAS# 105594-08-9 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 105594-08-9 | SDF | Download SDF |
PubChem ID | 184512 | Appearance | Powder |
Formula | C27H30O13 | M.Wt | 562.5 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 8-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-7-hydroxy-2-(4-hydroxyphenyl)chromen-4-one | ||
SMILES | CC1C(C(C(C(O1)OC2C(C(C(OC2C3=C(C=CC4=C3OC(=CC4=O)C5=CC=C(C=C5)O)O)CO)O)O)O)O)O | ||
Standard InChIKey | QWQINSCQRIBWBV-VEWXVMPQSA-N | ||
Standard InChI | InChI=1S/C27H30O13/c1-10-19(32)21(34)23(36)27(37-10)40-26-22(35)20(33)17(9-28)39-25(26)18-14(30)7-6-13-15(31)8-16(38-24(13)18)11-2-4-12(29)5-3-11/h2-8,10,17,19-23,25-30,32-36H,9H2,1H3/t10-,17+,19-,20+,21+,22-,23+,25-,26+,27-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Sophoraflavone A Dilution Calculator
Sophoraflavone A Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.7778 mL | 8.8889 mL | 17.7778 mL | 35.5556 mL | 44.4444 mL |
5 mM | 0.3556 mL | 1.7778 mL | 3.5556 mL | 7.1111 mL | 8.8889 mL |
10 mM | 0.1778 mL | 0.8889 mL | 1.7778 mL | 3.5556 mL | 4.4444 mL |
50 mM | 0.0356 mL | 0.1778 mL | 0.3556 mL | 0.7111 mL | 0.8889 mL |
100 mM | 0.0178 mL | 0.0889 mL | 0.1778 mL | 0.3556 mL | 0.4444 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 12beta-Acetoxy-3,7,11,15,23-pentaoxo-lanost-8,20-dien-26-oic acid
Catalog No.:BCX0020
CAS No.:1309931-91-6
- erythro-Austrobailignan-6
Catalog No.:BCX0019
CAS No.:114127-24-1
- Herbacetin 3-sophoroside-8-glucoside
Catalog No.:BCX0018
CAS No.:77298-68-1
- Regaloside I
Catalog No.:BCX0017
CAS No.:126239-78-9
- Dihydroconfertin
Catalog No.:BCX0016
CAS No.:68832-40-6
- Hosenkoside D
Catalog No.:BCX0015
CAS No.:156823-94-8
- 10-Deacetylcephalomannine
Catalog No.:BCX0014
CAS No.:76429-85-1
- Ganoderenic acid G
Catalog No.:BCX0013
CAS No.:120481-73-4
- Ganolucidic acid B
Catalog No.:BCX0012
CAS No.:98683-75-1
- 2-(2,4-Dihydroxyphenyl)-5,6-methylenedioxybenzofuran (ABF)
Catalog No.:BCX0011
CAS No.:67121-26-0
- 4-O-Coumaroylquinic acid
Catalog No.:BCX0010
CAS No.:53539-37-0
- Quercetin-3-O-[alpha-L-rhamnose-(1->2)-beta-D-glucopyranosyl]-5-O-beta-D-glucopyranoside
Catalog No.:BCX0009
CAS No.:1309795-36-5
- Ganoderic acid GS-3
Catalog No.:BCX0022
CAS No.:1206781-66-9
- 5-Hydroxy-4a,8-dimethyl-3-methylen-decahydroazuleno[6,5-b]furan-2(3H)-on
Catalog No.:BCX0023
CAS No.:114579-31-6
- Hainanic acid B
Catalog No.:BCX0024
CAS No.:1637737-46-2
- Kidjolanin
Catalog No.:BCX0025
CAS No.:38395-01-6
- Alopecurone A
Catalog No.:BCX0026
CAS No.:162558-89-6
- Gossypetin 3-sophoroside-8-glucoside
Catalog No.:BCX0027
CAS No.:77306-93-5
- 5-O-Coumaroylquinic acid
Catalog No.:BCX0028
CAS No.:32451-86-8
- Catechin 7-O-beta-D-glucopyranoside
Catalog No.:BCX0029
CAS No.:65597-47-9
- Odontoside
Catalog No.:BCX0030
CAS No.:20300-50-9
- Caffeoylcalleryanin
Catalog No.:BCX0031
CAS No.:20300-49-6
- Ganolucidic acid E
Catalog No.:BCX0032
CAS No.:114567-50-9
- Apigenin-6-C-beta-D-glucopyranosyl-8-C-[alpha-L-rhamnopyranosyl-(1->2)]-beta-glucopyranoside
Catalog No.:BCX0033
CAS No.:1646598-06-2
Inhibition of Cytochrome P450 Activities by Sophora flavescens Extract and Its Prenylated Flavonoids in Human Liver Microsomes.[Pubmed:31001351]
Evid Based Complement Alternat Med. 2019 Mar 13;2019:2673769.
Sophora flavescens possesses several pharmacological properties and has been widely used for the treatment of diarrhea, inflammation, abscess, dysentery, and fever in East Asian countries. S. flavescens is a major source of prenylated flavonoids, such as Sophoraflavone And kushenol. In this study, we examined the effects of S. flavescens extract and its prenylated flavonoids on cytochrome P450 (CYP) isoform activity in human liver microsomes. The extract inhibited CYP2C8, CYP2C9, CYP2C19, and CYP3A activities, with IC50 values of 1.42, 13.6, 19.1, and 50 microg/mL, respectively. CYP2B6 was only inhibited in human liver microsomes preincubated with the extract. CYP3A4 was more strongly inhibited by the extract in the presence of NADPH, suggesting that the extract may inhibit CYP2B6 and CYP3A4 via mechanism-based inactivation. Prenylated flavonoids also inhibited CYP isoforms with different selectivity and modes of action. Kushenol I, leachianone A, and sophoraflavone G inhibited CYP2B6, whereas kushenol C, kushenol I, kushenol M, leachianone A, and sophoraflavone G inhibited CYP3A4 via mechanism-based inhibition. Our results suggest that S. flavescens may contribute to herb-drug interactions when coadministered with drugs metabolized by CYP2B6, CYP2C8, CYP2C9, and CYP3A4.